Legal Representation
Attorney
A. Tally Eitan
USPTO Deadlines
Next Deadline
207 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
February 04, 2026
Extension Available
Until February 04, 2026
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 5, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 5, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jun 5, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 15, 2024 | ALIE | A | ASSIGNED TO LIE |
| Oct 15, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 15, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 15, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 1, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
| Jul 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 1, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
| Jul 1, 2024 | PETG | O | PETITION TO REVIVE-GRANTED |
| Jun 30, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Jun 30, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Mar 7, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 7, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Mar 7, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 6, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 6, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 27, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sep 26, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 31, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of parkinson's disease
Additional Information
Design Mark
The mark consists of the stylized wording "ONERJI" with two fading concentric incomplete circles to the left of and partially wrapping around the letter "O", with the outer circle being a semicircle and the inner circle being more than a semicircle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005